MDNA Life Sciences’ Study Reports That Mitochondrial DNA Deletions Accurately Detect Endometriosis in Circulating Blood

MDNA Life Sciences Inc. (MDNA) announced today that the results of a recent study have been published in the journal, Biomarkers in Medicine (Biomarkers In Medicine). The study reports the evaluation of mitochondrial DNA (mtDNA) deletions detected in blood plasma as promising biomarkers for the detection of endometriosis. Based on the performance reported in the publication, biomarkers of the mitochondrial genome, discovered through MDNAs proprietary Mitomic Technology™ platform, offer ground-breaking potential for a non-invasive test for endometriosis.

MDNA Life Sciences Appoints Orion Diagnostica as Exclusive Distributor in Key European Markets for the Mitomic® Prostate Test

MDNA Life Sciences Inc. (MDNA), the molecular diagnostics company revolutionizing the development of liquid biopsy biomarkers based on the mitochondrial genome, announced today that it has appointed Orion Diagnostica Oy (Orion) as the exclusive distributor for the Mitomic® Prostate Test (MPT™) in Germany, Denmark, Finland, Sweden, Norway, Poland, Czech Republic, Slovakia, and Hungary.

MDNA Life Sciences announces the worldwide availability of the CE marked Mitomic® Prostate Test Real-Time PCR Kit

WEST PALM BEACH, FL / ACCESSWIRE / October 9, 2018 / MDNA Life Sciences Inc. (MDNA), the molecular diagnostics company revolutionizing the development of liquid biopsy biomarkers based on the mitochondrial genome, announced today that the Mitomic® Prostate Test (MPT™) Real-Time PCR Kit is now CE marked and being made available worldwide.

MDNA Life Sciences Agrees Licensing Deal with Aspire Pharma Ltd for the Mitomic® Prostate Test in the UK

MDNA Life Sciences Inc. (MDNA), the molecular diagnostics company revolutionizing the development of liquid biopsy biomarkers based on the mitochondrial genome, announced today that it has agreed a licensing deal with Aspire Pharma Ltd. (Aspire) in the UK for the Mitomic® Prostate Test (MPT™). On the heels of recent news that MDNA’s CE marked MPT™ Real-Time PCR kit is now commercially available, this is the first international partner to be announced by MDNA and is the start of the global roll-out of MPT™through a growing network of distribution partners.